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The pathogenesis of edema in the nephrotic syndrome (NS) is
classically explained by a decrease in blood volume secondary to
low plasma colloid osmotic pressure () [1], resulting in stimula-
tion of renal sodium reabsorption via neural [2] and endocrine [3]
pathways. However, we have previously measured blood volume
in a large group of adult nephrotic subjects and found values
predominantly within the normal range [4]. Compensatory mech-
anisms such as a decrease in interstitial appear to play a major
role in the defense of circulating blood volume in the NS [5].
Children with acute relapse of the NS often show symptoms
such as abdominal pain, oliguria, cold extremities, anorexia and
diarrhea that are rapidly ameliorated by infusing albumin, and
hence are attributed to hypovolemia [6]. On the other hand, such
albumin infusions are frequently complicated by hypertension,
congestive heart failure and pulmonary edema [7]. Measurements
of blood volume in nephrotic children are sparse. Both low and
high volumes [8—10] have been suggested in preliminary reports.
However, blood volume was usually computed from albumin
distribution volume and hematocrit, which is relatively insensitive
because the relation between whole-body hematocrit and large-
vessel hematocrit, the so-called F-cell ratio [11], is not constant
between individuals. The F-cell ratio is sensitive to changes in
distribution of the circulation between the microvasculature
(where the hematocrit is low due to the Fahreus-Lindqvist effect)
and the large vessels. Considering the large spontaneous variation
found in blood volume measured by plasma volume and hemat-
ocrit in healthy adults [12] and children [131, it is questionable
whether a decreased blood volume can actually be measured with
this approach in nephrotic children.
Simultaneous measurements of plasma volume and red cell
volume, providing more reliable assessment of whole blood
volume, are not available in normal children. Recently we found
that children with or without symptoms of hypovolemia due to
relapse of minimal change nephrosis had blood volumes that were
not different from children in remission [14]. However, it is not
certain whether the latter group have blood volumes that fall
within the normal range, and can serve as a reference group. The
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only reference values that are available in children are for blood
volume calculated from plasma volume and hematocrit [13]. Also,
it is unknown whether children with nephrotic syndrome are
compensating for factors that are threatening blood volume by
altering the distribution of blood volume between the microvas-
culature and the large vessels [15].
To address these questions, we measured plasma volume, as the
distribution volume of iodinated-albumin, and red cell volume,
and calculated the F-cell ratio in children over a large age bracket
during nephrosis and in remission. Our aims were: (1) to define a
reference range for plasma volume, red cell volume, blood volume
and F-cell ratio in children without proteinuria between the age of
2 and 18 years; (2) to establish whether these variables fall inside
or outside these defined ranges in children with nephrotic pro-
teinuria; and (3) to elucidate whether plasma iT correlates with
blood volume or F-cell ratio.
Methods
Patient characteristics
Patients were classified as being nephrotic when they had a
protein/creatinine ratio in their urine above 0.6 g/mmol, plasma
albumin below 25 g/liter, and detectable edema. They were
classified as being in remission when urinary protein/creatinine
ratio was below 0.4 g/mmol, plasma albumin was above 30 g/liter,
in the absence of edema, A 24-hour urine collection was not
feasible in most patients, and hence the protein/creatinine ratio
was used to estimate urinary protein loss [16]. In a group of
children with minimal change nephropathy (N = 34), we studied
31 while they were in remission and 21 while they were nephrotic.
In addition, we included six children with NS due to histological
lesions (4 with mesangioproliferative glomerulonephritis, one
with focal glomeruloscierosis and one with IgA nephropathy).
Patients were selected to have normal or at most modestly
disturbed renal function (serum creatinine below 100 j.mol/liter).
Eleven of the patients in remission were on steroid treatment.
Treatment with diuretics was terminated at least one week before
the start of the trial. Urine was collected prior to the start of the
trial. Informed consent of all parents and guardians was obtained.
The study was performed in accordance with the Declaration of
Helsinki, and was accepted by the Ethical Committee of the
Wilhelmina Childrens Hospital in Utrecht.
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Volume measurements
On the morning of the volume determination 5 ml venous blood
was drawn for red blood cell (RBC) labeling with 51Cr [171,and
the left and right cephalic veins were catheterised. After at least
30 minutes of recumbency 4 ml blood was drawn to serve as a
blankS and for determination of plasma colloid osmotic pressure
(ir), total protein, and hematocrit. Then 1311-HSA (human serum
albumin, Amersham, UK) was injected into the laminar stream of
a 10 ml pulse of saline solution via the rubber extension of a
T-extension set (Abbott). This procedure was designed to avoid
adhesion of the tracer to the catheter or connection set. The
syringe was rinsed by flushing twice with saline, and residual
radioactivity in all used material was subtracted from total counts
in the syringe. Exactly 10 minutes later 4 ml blood was drawn from
the contralateral arm for counting of radioactivity. Subsequently
5TCr-RBC was administered by the same procedure. The radio-
active doses (in msv) were calculated according to the subjects'
age as follows: '311-HSA = 0.0061 X years and 51Cr-RBC =
0.0073 >< years, and therefore varied per subject. Potassium iodide
was administered orally 12 hours prior to administration of
1311-HSA Hematocrit was determined in triplicate. Plasma ir was
measured with a strain-gauge oncometer. Plasma and urine
protein were measured by the biuret reaction. Plasma and urine
creatinine were measured by the Jaffe reaction.
Calculations
Diy weight was measured as body wt when the patients were in
remission or estimated (from age, height and lowest body wt
measured during treatment with diuretics and low dietary sodium
prior to the study) as edema-free body wt in the patients with
histological lesions, or with minimal lesions who did not go into
spontaneous remission. Blood volume was calculated as red cell
volume + plasma volume. Whole-body hematocrit was calculated
as red cell volume/blood volume, the F-cell ratio as whole-body
hematocrit/large vessel hematocrit. Body surface area was esti-
mated using height (H) and dry body wt (DBW) with the formula
of Dubois and Dubois [181. Due to the difference in body
composition between males and females [19], pubertal or older
females (usually above the age of 10) should be analyzed sepa-
rately. Lean body mass (LBM) was estimated from H and DBW
according to the formulae:
LBM in males and prepubertal females: 0.407 DBW + 26.7 H — 19.2
LBM in pubertal or older females: 0.252 DBW + 47.3 H — 48.3.
These formulae have previously been derived from the empir-
ical relation between total body water (TBW), body wt and height
on the one hand and between TBW and LBM (in kg) on the other
hand [12]. Elimination of TBW gives LBM (in kg) as a function of
DBW (in kg) and height (in m). Regression of plasma volume, red
cell volume and blood volume of the patients in remission on age,
H, DBW, BSA and LBM were calculated in order to derive the
most suitable index, that is, with the highest correlation coefficient
in combination with an intercept that was closest to zero. This
appeared to be LBM (Results).
Linderkamp et al [13] have measured plasma volume and
hematocrit in 85 healthy children (39 and 46 )between 2 and
14 years of age. They calculated blood volume using an assumed
F-cell ratio of 0.91 [20, 21]. We evaluated whether the patients in
Table 1. Clinical data of patients with the nephrotic syndrome (NS)
due to minimal lesions (ML), histological lesions (HL), or in remission
Diagnosis Remission MLNS HLNS
Gender, male! 22/9 13/8 4/2
female
Age years 7.9 (2.4—18.2) 7.0 (2.2—16.3) 6.0 (3.9—10.7)
Length cm 129 (91—176) 121 (86—161) 106 (102—130)
Dry body 25.6 (12.0—63.5) 20.0 (11—54) 17.5 (15—27)
weight
kg DBW
Body surface 0.94 (0.54—1.70) 0.79 (0.50—1.55) 0.72 (0.66—0.98)
area m2
Edema % DBW
Urinary protein/
—
0.02 (0.00—0.38)
9 (326)a
1.59 (0.61_8.4)a
5 (42O)h
1.30 (l.i3_S.l)b
creatinine
g/mmol
Plasma protein 67 (58—82) 43 (3248)a 45 (35.5])h
g/liter
Plasma r 23.4 (18.6—29.0) 7.9 (6.0_17.0)a 10.9 (75160)b
mm Hg
Plasma creatinine 46 (19—86) 45 (12—67) 50 (45—99)
pmol/liter
Hematocrit % 37 (33—42) 39 (3 1—46) 30 (2235)b
Data are presented as median and range and were analyzed with a
Kruskall-Wallis test followed by a Mann-Whitney U-test.
a P < 0.05, remission vs. MLNSbP < 0.05, remission vs. HLNS
remission had a similar range of values at a given age for blood
volume calculated in the same manner. Subsequently, the red cell
volume, plasma volume and blood volume in the nephrotic
patients were normalized to LBM and compared with the nor-
malized values as established in the subjects in remission. The
F-cell ratio was also compared. Linear regression analysis of F-cell
ratio on LBM was performed for the patients in remission and for
blood volume and F-cell ratio on plasma r for the whole
population (subjects in remission plus nephrotic subjects).
Statistical analysis
Data are presented as median and range. Comparison of data
from groups was performed with the Kruskall-Wallis test followed
by the Mann-Whitney U-test. Paired data were compared with the
Wilcoxon test. Linear regression and correlation coefficients were
calculated by the least squares method. Regression lines were
compared by analysis of covariance.
Results
The patient characteristics are presented in Table 1. There were
about twice as many males in each group. The median age (and
thus length, weight and body surface area) of patients with
histological lesions was slightly lower than those in the other two
groups. By definition edema was absent, urine protein/urine
creatinine was very low and plasma protein and iwere normal in
patients in remission. The amount of edema in both groups of
nephrotic patients showed a large variation, but the median values
did not differ significantly. Plasma protein and r were reduced in
both groups of nephrotic patients. Plasma creatinine was similar
in all groups, and not increased. Hematocrit was somewhat
reduced in patients with histological lesions.
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Age, years
Fig. 1. Blood volume (plasma voiume/1—O.91(hematocrit)) per kg body wt
in relation to age in 22 boys [Gland 9 girls i•j, aged 2 to 18 years for patients
in remission from minimal change nephrotic syndrome. The continuous and
dashed lines identify the normal range (twice the SD) obtained in
respectively 39 boys and 46 girls aged 2 to 14 years from a study by
Linderkamp et al [13] in healthy children.
Remission
Blood volume was calculated from measured plasma volume,
hematocrit and an assumed F-cell ratio of 0.91 in order to
compare data from the present study with those found by
Linderkamp et al [131 in 85 healthy children, aged 2 to 3 years
(N = 17), 4 to 6 years (N = 16), 7 to 10 years (N = 24) and 11 to
14 years (N = 28). Because Linderkamp et al [13] provide
separate values for boys and girls, the normal range for both
genders (twice the SD) was plotted in Figure 1. Plotting our data
from the children in remission over this range reveal that these
data lie within or directly above or below the normal range,
without a consistent deviation in either direction, Five subjects in
remission were older than 14 years, but the values in these
subjects did not deviate from the range found in the younger
patients. This finding supports the view that the data that we
measured in subjects in remission can safely be used as a
reference frame.
The mean values of plasma volume, red cell volume and blood
volume (calculated as the sum of these two compartments),
normalized for age, height, dry body wt (DBW), body surface area
(BSA) or lean body mass (LBM) of the patients in remission are
listed in Table 2. There were differences between males and
females for volumes normalized by height, DBW and BSA, but
this was not the case for the volumes normalized for age or LBM.
All volumes were highly correlated with age, height, DBW, BSA
and LBM (all P < 0.00 1), but the intercepts of the linear
regression lines for blood volume normalized for age, height,
DBW and BSA were much further from zero than that of the
regression line normalized for LBM (Table 3). The regression
lines of plasma volume, red cell volume or blood volume on LBM
did not differ significantly for males and females. For these
reasons, LBM was elected as the index for normalization of body
fluid volumes, independent of gender.
The reference range of blood volume as a function of LBM is
shown in Figure 2A. The normal range was defined as the area
within twice the SD. Males and females were evenly distributed
throughout the range of LBM (10 to 53 kg). The F-cell ratio
showed no relation to LBM (Fig. 3) The median and range of the
Gender
N
Male
22
Female
9 P
PV/age mi/year 183 (126—324) 176 (127—250) NS (0.965)
PV/height 1.19 (0.83—1.89) 0.93 (0.62—1.92) NS (0.098)
liter/rn
PV/DBW mi/kg 53.2 (38.4—66.1) 47.3 (31.9—55.3) NS (0.068)
PV/BSA
liter/rn2
1.47 (1.20—1.89) 1.20 (0.98—1.96) 0.019
PV/LBM mi/kg 58.3 (44.6—67.0) 54.0 (44.5—73.8) NS (0.572)
RCV/age mi/year 89 (65—128) 86 (68—98) NS (0.514)
RCV/height 0.52 (0.33—0.91) 0.49 (0.25—0.65) NS (0.177)
liter/m
RCV/DBW 24.6 (18.3—34.1) 20.4 (15.7—25.4) 0.007
mi/kg
RCV/BSA
liter/rn2
0.67 (0.50—1.05) 0.60 (0.43—0.69) 0.015
RCV/LBM mi/kg 26.2 (20.7—36.0) 25.0 (21.2—28.1) NS (0.277)
By/age mI/year 276 (205—451) 253 (195—348) NS (0.828)
By/height liter/rn 1.73 (1.15—2.79) 1.41 (0.90—2.57) NS (0.128)
BV/DBW mi/kg 78.2 (60.0—98.0) 72.5 (47.5—76.6) 0.012
BV/BSA
liter/rn2
2.16 (1.77—2.72) 1.75 (1.48—2.62) 0.013
BV/LBM mi/kg 84.9 (68.8—95.3) 75.2 (66.4—98.7) NS (0.602)
F-cell ratio 0.84 (0.77—1.09) 0.81 (0.72—0.92) NS (0.240)
Slope Intercept ml r P
BV/Age year
BV/T-Ieight rn
BV/DBW
BV/BSA
BV/LBM
218 ml/year
3936 mI/rn
60.2 mI/kg
2678 mI/rn2
81.1 mI/kg
359
—2853
408
—534
27
0.950
0.935
0.908
0.937
0.953
<0.0005
<0.0005
<0.0005
<0.0005
<0.0005
F-cell ratio were found to be 0.83 (0.72 to 1.09; N = 31). The
F-cell ratio in males and in females was 0,84 (0.77 to 1.09; N = 22)
and 0.81 (0.72 to 0.92; N = 9), respectively. These values were also
not significantly different.
Nephrosis
The body fluid volumes normalized for LBM and the F-cell
value found in the nephrotic patients without and with histological
lesions and for those in remission are shown in Table 4. The
volumes for boys and girls are not presented separately because
the inherent gender-related differences have been corrected for by
using the appropriate normalization to LBM (see above). No
differences were observed in the patients with minimal lesions in
comparison to the patients in remission, irrespective of whether
this was tested for the entire group or for the subgroup of 18 for
which paired data were available. In the patients with histological
lesions who were mildly anemic, plasma volume tended to be
higher and red cell volume lower than the patients in remission,
but blood volume and F-cell ratio were normal. No differences
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Table 2. Plasma volume (PV), red cell volume (RCV) and blood
volume (BV) normalized for age, height, dry body weight (DBW), body
surface area (BSA) or lean body mass (LBM) as well as the F-cell ratio
of the male and female patients in remission
Data are presented as median and (range) and were analyzed with a
Mann-Whitney U-test.
Table 3. Linear regression for blood volume versus age, height, dry
body weight (DBW), body surface area (BSA) or lean body mass(LBM) of the patients in remission (N = 31)
1474 Vande Walle et al: Blood volume in children with NS
Lean body mass, kg
Fig. 2. A. Blood volume (red cell volume + plasma volume) plotted against
lean body mass in 22 boys [0] and 9 girls j•j, aged 2 to 18 years in remission
from minimal change nephrotic syndrome. The normal range is defined as
twice the SD and is identified by dashed lines. B. Blood volume (red cell
volume + plasma volume) plotted against lean body mass in 21 patients
with minimal change nephrotic syndrome (Lx) and 6 patients with ne-
phrotic syndrome due to histological lesions (A). The normal range as
defined in A is indicated by dashed lines.
were observed between patients with minimal or histological
lesions. Blood volume in all nephrotic subjects lies within the
normal range found in the control population in remission (Fig.
2B). The regression lines of blood volume on LBM for nephrotic
patients and subjects in remission were not significantly different.
To observe whether a subgroup of patients with a particularly
low or high plasma colloid oncotic pressure (ir) were, respectively,
hypovolemic or hypervolemic we plotted blood volume/LBM
against IT (Fig. 4) and calculated the regression of blood volume,
normalized to LBM, on 'ar. No clear differences in blood volume
could be observed over a range of IT that varied from 6 to 29 mm
Hg, and there was no significant correlation. Similarly, the F-cell
ratio did not differ over a large range of IT, with the exception of
four nephrotic patients with IT ranging from 6.4 to 8.3 mm Hg
(Fig. 5), where the F-cell ratio was below 0.7. Note, however, that
11 other patients with similarly low values for IT had a normal
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Table 4. Plasma volume (PV), red cell volume (RCV) and blood
volume (BV) normalized for lean body mass (LBM) and the F-cell
value of patients with the nephrotic syndrome (NS) due to minimal
lesions (ML), histological lesions (HL), or in remission
Diagnosis Remission MLNS HLNS
All patients
N 31 21 6
PV/LBM 58.3 (44.5—73.8) 55.0 (40.6—94.4) 66.2 (47.8
mi/kg
RCV/LBM 25.4 (20.7—36.0) 25.5 (18.2—40.0) 21.5 (13,9_32.4)h
mi/kg
BV/LBM 84.6 (66.4—98.7) 78.9 (67.5—123.4) 87.8 (69.9—99.6)
mi/kg
F-cell ratio 0.83 (0.72—1.09) 0.81 (0.59—1.07) 0.83 (0.68—1.02)
Paired data
N 18 18
PV/LBM 58.3 (44.5—67.0) 53.9 (40.6—78.9)
mi/kg
RCV/LBM 24.5 (20.7—31.1) 24.6 (18.2—27.8)
mi/kg
BV/LBM 84.9 (66.4—95.3) 77.0 (67.5—104.0)
mi/kg
F-cell ratio 0.82 (0.75—0.92) 0.82 (0.67—1.07)
Data are presented as median and (range) and were analyzed with a
Kruskall-Wallis test followed by a Mann-Whitney U-test. Paired analysis
of the patients with MLNS studied both in remission and during relapse
was also performed using a Wilcoxon test, a 0.058, b 0.039, HLNS vs.
remission
F-cell ratio above 0.7. There was a very weak relation between
F-cell ratio and IT (r = 0.251, P = 0.051, N = 58).
Discussion
In this study a reference frame for blood volume, normalized to
LBM and measured directly from plasma volume and red cell
volume, was established for children between the age of 2 and 18
years that is independent of gender. Directly measured blood
volume in children with the NS fell within this defined normal
range. The ratio of whole-body hematocrit to large-vessel hemat-
ocrit (the F-cell ratio) was not lower in children than in adults, and
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0 10 20 30 40 50 Fig. 3. F-cell ratio (whole-body hematocrit/peripheral hematocrit) in rela-
tion to lean body mass (LBM) in 22 boys [0] and 9 girls [S], aged 2 to 18
B Lean body mass, kg years. All subjects were patients in remission from minimal change
nephrotic syndrome. The normal range is defined as twice the so and is
identified by dashed lines. There was no significant relation between LBM
and F-cell ratio.
0 10 20 30 40 50
Vande Walle et al: Blood volume in children with NS 1475
was not disturbed in children with the NS, with the exception of a
small minority of the patients with vety low .
The observation that the intercept of the relation between
blood volume and LBM did not differ significantly from zero in
subjects aged 2 to 18 years directly confirms a similar observation
in adult subjects in our laboratory [12]. In this previous study the
subjects' age varied from 19 to 72 years [12], so that we are now
able to support the correction for LBM for individuals between 2
and 72 years of age. Direct comparison of plasma volume/LBM as
measured in the 31 children in remission (56.6 7.5 mI/kg) with
plasma volume!LBM in 66 normal adult subjects (56.2 6.2
ml/kg) in the previous study [12] revealed no significant difference,
but red cell volume/LBM was significantly lower in the children
(26.2 3.9 ml/kg) than in a group of 12 adults (34.2 2.4 ml!kg;
P < 0.01) [22]. Hence, the (plasma volume + red cell volume)!
LBM in the children (82.8 9.1 mI/kg) was also significantly
lower than the value found in the adult subjects (94.4 4.5 ml!kg;
P < 0.01) [22]. Therefore, it is advisable to use separate reference
values for the children and adults for the direct comparison of
blood volume because of the difference in red cell volume. The
difference in hematocrit between the adults (42%) and the
children (37%) is an illustration of this fact.
The frame of reference for blood volume in children estab-
lished in this study provides an important tool for further study of
conditions in children where an alteration in blood volume has
been postulated. Expansion of blood volume is thought to play an
important role in the pathogenesis of hypertension [23] and!or
diabetic nephropathy [24]. In other disease states such as cardiac
failure, severe liver disease with hepato-renal syndrome or bron-
chopulmonary dysplasia changes of blood volume may be impor-
tant, but until our study, no reference data were available for
children.
Hypoalbuminemia has been postulated to increase capillary
permeability to albumin [25]. If this is true at albumin concentra-
tions found in vivo this would lead to overestimation of plasma
volume, and thus result in a lower F-cell ratio. An increased
capillary permeability to albumin will lead to overestimation of
plasma volume, while in fact plasma volume is maintained in the
presence of increased flux of albumin through interstitium and
lymphatics. However, in adult patients with the NS we were
unable to find a change in F-cell ratio [221. The transcapillary
escape rate of albumin in normals ranges from 4 to 7%/hr and
from 5 to 14%/hr in adult nephrotic subjects [22]. It should be
noted that even if the capillary permeability to albumin was
increased to the upper end of this range in nephrotic children this
would have little impact on measured plasma volume, because the
latter is measured as the 10-minute distribution volume of albu-
min, at which time at most 3% of the tracer will have been lost
through the capillaries instead of the usual loss of 1% [26]. In
healthy infants below the age of one year capillary permeability to
albumin is known to be as high as 6%/lO minutes [20, 27].
However, the mean F-cell ratio in the healthy children above two
years old in the present study (0.85 0.07) was not significantly
different from that found in our laboratory in healthy adults (0.86
0.03 [221). This does not exclude a slightly higher capillary
permeability to proteins in children, but if present it is apparently
accompanied by a weaker Fahreus-Lindqvist effect, so that there
is no net effect on F-cell ratio.
Reports of direct measurement of blood volume in nephrotic
children are sparse [8—10], and two of these are preliminary [8,
10]. As in our study, most of the patients were males. This
gender-related difference in incidence of the NS in children is well
known [28], albeit unexplained. Masuda et al [8] found hypovo-
lemia in edematous children when compared to remission,
whereas Li, Wang and Lu [10] found the reverse. Ormantaeva
found hypovolemia only in young children with NS, but the
reference population was not defined [9]. None of these reports
provide absolute values for the measured blood volume. In the
present study blood volume in the nephrotic children was not
different from that found in the control population. This confirms
previous observations from our department in adults with the
nephrotic syndrome [22], but is in direct contrast to what has been
reported by others in large series of adult patients [29, 30]. Part of
the confusion may be due to the fact that blood volume measure-
ments by this group have been related to wet body wt [29, 30].
Clearly, patients who have accumulated large amounts of edema
in the compliant interstitial space (a threefold increase in extra-
cellular fluid volume has been recorded [31]) will be categorized
as being hypovolemic with this approach.
Redistribution of extracellular protein from the intravascular to
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(ii-). There was no significant relation between blood volume and was a very weak relation between F-cell ratio and iT (r = 0.251, P =
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the extravascular space probably supports blood volume ho-
meostasis in patients with a stabilized hypoproteinemia [5, 32]. It
is well known that an acute decrease in plasma ir, induced by
plasma pheresis, will induce hypovolemia [33]. However, 20 hours
later normovolemia is present without restoration of normopro-
teinemia [34]. In patients with an established NS the decrease in
plasma is matched by a decrease in interstitial fluid r [32, 35,
36], so that the transcapillary colloid osmotic gradient (plasma
r—interstitial fluid ) is maintained. These findings, as well as the
observation that when patients with edema come into remission a
negative sodium balance can be maintained for several days
despite severe hypoproteinemia [371, have lead to the postulate
that a primary defect in renal sodium handling is responsible for
sodium retention in these patients [4, 26, 381. This is supported by
direct observations in different models of experimental nephrosis
[39—42].
A situation can be conceived in which proteinuria is so pro-
tracted and severe that interstitial protein stores become depleted
and the transcapillary gradient of r is seriously compromised,
resulting in edema via the classical "underfill" pathway. The
experimental work performed in dogs indicated that this occurs
below a plasma r of about 8 mm Hg [34], a value termed the
oncotic threshold for edema formation. There were 15 NS pa-
tients with a value of - below 8.4 mm Hg (6.0 to 8.3). However,
even in this range no relation was present between plasma ir and
blood volume (Fig. 5). One possibility is that interstitial IT is
appropriately decreased in these patients. But this would imply an
interstitial r close to zero, which is unlikely because of the
continuous flux of plasma proteins through the capillary mem-
brane to the interstitial space. The other possibility is that
non-albumin protein, that is retained to a greater extent in the
vascular space, is contributing importantly to plasma ir, as has
previously been found in adult patients with NS [31. The F-cell
ratio was decreased in a minority of these patients (3 of 15 =
20%) with the most severely decreased plasma . It is conceivable
that in these three patients there was some increase in capillary
permeability causing overestimation of plasma volume and thus
decreasing the F-cell ratio. The corollary of this argument is that
in this subgroup some degree of hypovolemia was present.
However, when effective circulating blood volume is threatened,
peripheral vasoconstriction mobilizes fluid reserves. This mecha-
nism decreases the circulation to the small vessels and thus, if
anything, tends to increase the F-cell ratio, as has been observed
in dogs after bleeding 30% of blood volume [44]. Thus whether
these children were truly hypovolemic is not certain.
In summary, normal reference frames for blood volume, mea-
sured as the sum of red cell volume and plasma volume and
adequately normalized for LBM, and F-cell ratio, the ratio of
whole-body and large-vessel hematocrit, were defined in children.
Blood volume was not found to be subnormal in a large group of
pediatric patients with a marked decrease in plasma ir due to the
NS. A slight decrease in F-cell ratio was observed in a minority of
patients with plasma r below 8.3 mm Hg. This may indicate a
decrease in blood volume in this subcategory that would have
remained undetected by measurements of plasma volume and
hematocrit only. Thus, when using a rigorously defined normal
range, we could find practically no evidence of hypovolemia in
nephrotic children.
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